Agilent Technologies, Inc. logo
Agilent Technologies, Inc. (A)
Compare

Agilent Technologies, Inc. (A) EBITDA Margin: 26.41%

popular:market cap|pe ratio|revenue|price history|total return

Is Agilent Technologies, Inc.’s EBITDA margin high or low?

Agilent Technologies, Inc.'s EBITDA margin of 26.41% is in line with its 5-year average of 26.47%, around the middle of its 5-year range (23.00%–28.79%).

The EBITDA margin for Agilent Technologies, Inc. (A) is 26.41% as of Wednesday, June 10, 2026. It is below its 12-month average by 4.31% (27.60%).

EBITDA|Gross Margin|Operating Margin|Profit Margin|All Metrics

A EBITDA Margin Chart

A EBITDA Margin
26.41%-8.27% 1Y
Zoom

A Average EBITDA Margin Chart

A Current vs Average EBITDA Margin Chart

A EBITDA Margin Metrics

EBITDA MARGIN

26.41%

EBITDA MARGIN AVG TTM

27.60%

EBITDA MARGIN AVG 3Y

26.98%

EBITDA MARGIN AVG 5Y

26.47%

EBITDA MARGIN AVG 10Y

24.78%

EBITDA MARGIN AVG 15Y

23.14%

EBITDA MARGIN AVG 20Y

20.60%

CURRENT VS TTM AVG

-4.31%

CURRENT VS 3Y AVG

-2.13%

CURRENT VS 5Y AVG

-0.23%

CURRENT VS 10Y AVG

+6.59%

CURRENT VS 15Y AVG

+14.14%

CURRENT VS 20Y AVG

+28.20%

A Competitors' EBITDA Margin

NAMEMARKET CAPEBITDA MARGINTTM3Y5Y
Agilent Technologies, Inc. (A)—26.41%27.60%26.98%26.47%
Zoetis Inc. (ZTS)$34.20B42.98%42.41%42.38%41.76%
Humana Inc. (HUM)$43.78B2.24%2.50%3.66%4.53%
IDEXX Laboratories, Inc. (IDXX)$44.47B34.13%33.43%32.56%31.99%
Centene Corporation (CNC)$31.94B-2.64%0.58%1.90%2.49%
IQVIA Holdings Inc. (IQV)$30.60B21.24%21.82%21.39%20.63%
DexCom, Inc. (DXCM)$29.24B24.96%24.20%23.29%21.36%
Biogen Inc. (BIIB)$29.00B31.60%31.28%30.38%32.54%
Veeva Systems Inc. (VEEV)$27.37B28.68%27.64%24.37%25.68%
Waters Corporation (WAT)$23.83B31.97%33.50%33.77%33.93%

Margin Comparison

Gross Margin

52.4%

EBITDA Margin

26.4%

Operating Margin

21.3%

Net Margin

18.8%

Formula: EBITDA Margin = (EBITDA / Revenue) × 100

Why EBITDA Margin matters:

  • Removes effects of depreciation policies (D&A)
  • Capital structure neutral (ignores interest)
  • Tax neutral (ignores tax differences)
  • Good proxy for operating cash generation

Agilent Technologies, Inc. EBITDA Margin Formula & Definition

EBITDA Margin = EBITDA / Revenue

EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Agilent Technologies, Inc. EBITDA Margin FAQ

What is the EBITDA margin for Agilent Technologies, Inc. (A)?
The EBITDA margin for A stock is 26.41%.
Is Agilent Technologies, Inc.'s EBITDA margin high or low?
Agilent Technologies, Inc.'s EBITDA margin of 26.41% is in line with its 5-year average of 26.47%, around the middle of its 5-year range (23.00%–28.79%).
What is the TTM average EBITDA margin for Agilent Technologies, Inc. (A)?
The TTM average EBITDA margin for A stock is 27.60%.
What is the 3Y average EBITDA margin for Agilent Technologies, Inc. (A)?
The 3Y average EBITDA margin for A stock is 26.98%.
What is the 5Y average EBITDA margin for Agilent Technologies, Inc. (A)?
The 5Y average EBITDA margin for A stock is 26.47%.
What is the 10Y average EBITDA margin for Agilent Technologies, Inc. (A)?
The 10Y average EBITDA margin for A stock is 24.78%.
What is the 15Y average EBITDA margin for Agilent Technologies, Inc. (A)?
The 15Y average EBITDA margin for A stock is 23.14%.
What is the 20Y average EBITDA margin for Agilent Technologies, Inc. (A)?
The 20Y average EBITDA margin for A stock is 20.60%.

Agilent Technologies, Inc. EBITDA Margin History

DATEEBITDA MARGIN
2025-10-3126.41%
2024-10-3128.79%
2023-10-3124.92%
2022-10-3127.82%
2021-10-3127.88%
2020-10-3123.00%
2019-10-3123.84%
2018-10-3125.05%
2017-10-3124.51%
2016-10-3120.54%
2015-10-3119.79%
2014-10-3117.86%
2013-10-3119.47%
2012-10-3121.07%
2011-10-3120.73%
2010-10-3118.53%
2009-10-315.74%
2008-10-3119.73%
2007-10-3114.30%
2006-10-3112.75%
2005-10-319.89%
2004-10-316.70%
2003-10-31-8.01%
2002-10-31-14.51%
2001-10-31-0.52%
2000-10-3114.78%
1999-10-3112.62%
1998-10-3111.56%

Related Metrics

EBITDAGross MarginOperating MarginProfit MarginAll Metrics

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Santa Clara, CA
17,900 employees
www.agilent.com
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Padraig McDonnell
View full financials